Clearside Biomedical, Inc. (CLSDQ)
0.79
-0.11
(-12.22%)
USD |
OTCM |
Dec 05, 16:00
Clearside Biomedical Shareholders Equity (Quarterly): -53.95M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 6.741B |
| Eli Lilly & Co. | 23.79B |
| Mersana Therapeutics, Inc. | -59.54M |
| Inspire Medical Systems, Inc. | 666.46M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.64M |
| Total Liabilities (Quarterly) | 65.59M |
| Debt to Equity Ratio | -1.142 |
| Current Ratio | 2.980 |
| Net Debt Paydown Yield | -13.49% |